Sep 12, 2024
The Changing Landscape of Nutrition in Medicine
A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…
Resources
Sep 11, 2024
Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment
Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key Takeaways Up to 19% of prevalent dementia cases may be…
Sep 9, 2024
AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME
By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…
Aug 21, 2024
AOA urges eye care provider consultation before use, purchase of MSM eye drops
August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a company that manufactures eye drops that claim to change eye…
Aug 15, 2024
Prevalence of AMD-related vision loss expected to increase as population ages
By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older age is associated with greater prevalence of AMD-related vision loss.…
Aug 12, 2024
Sandoz announces FDA approval for new biosimilar
New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection. Enzeevu is indicated to…
Aug 12, 2024
Multivitamins could potentially shorten your lifespan
By Lisa Marie Basile | Fact-checked by Davi Sherman | Published July 16, 2024 Key Takeaways A new cohort study published in JAMA Network Open analyzed data from nearly 400,000 participants over 20 years and found that the use…
Aug 9, 2024
Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli
New Study Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release. The FDA…
Aug 6, 2024
AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD
by: Steven Ferrucci, OD, FAAO Key takeaways: The AREDS2 supplement slowed the expansion of geographic atrophy toward the fovea by approximately 55% over 3 years in patients with dry AMD.…
Jul 28, 2024
Stave off cognitive decline: Eat this mushroom
By Julia Ries | Fact-checked by Davi Sherman | Published July 25, 2024 Key Takeaways The lion’s mane mushroom is gaining popularity for its potential health benefits, particularly in supporting memory and preventing cognitive decline. Mushrooms, including…
Jul 26, 2024
Heart Pounding, Stomach-Knotting: Stress & You
The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress feels like. The “fight or flight” response is behind it:…
Jul 25, 2024
Could Metformin Fill the Bill for Geographic Atrophy Prevention?
Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in…
Jul 8, 2024
FDA approves Vabysmo prefilled syringe for retinal diseases
Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The syringe will be available in the U.S. later this year.…
Jul 1, 2024
AI model helps predict anti-VEGF response in diabetic macular edema
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Luvisi and…
Jun 25, 2024
Utilizing the immune system to combat dry eye disease
by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED) is a chronic and often progressive condition that can be…
Jun 25, 2024
Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy
By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…
Jun 11, 2024
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The FDA cleared the Abbott Lingo for adults who want to…
Jun 10, 2024
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting…
Jun 6, 2024
Avirmax Biopharma Inc receives IND approval from FDA
June 6, 2024 by: Martin David Harp The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular…
Jun 6, 2024
Stealth BioTherapeutics enrols first subject in dry AMD treatment trial
A new dry AMD study. The rate of change in the macular area of photoreceptor loss is the primary efficacy endpoint of ReNEW and ReTAIN trials. Stealth BioTherapeutics has enrolled…
May 30, 2024
FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization
First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients Manassas, VA (May 16, 2024) Digital healthcare provider, Notal Vision,…
May 30, 2024
Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD
May 28, 2024, by; Lynda Charters Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the…
May 22, 2024
Press Release
Discover Hope Macular Degeneration Association Connects Patients with Vital Support Macular Degeneration Association offers free resources and events for all SARASOTA, Fla. (May 14, 2024) – The Macular Degeneration Association…
May 12, 2024
Happy Mother’s Day
…
May 3, 2024
16 Ways to Modify Your Home if You Have Diabetic Macular Edema
Low vision can increase your risk of a fall or other mishap. Here’s a room-by-room guide to making your home safer if you have DME. By Maria Masters Medically Reviewed …
May 3, 2024
Study finds link between body weight and retinal thickness
There appears to be a significant association between body weight, specifically preobesity and obesity, and changes in retinal thickness, according to a study that suggests individuals who are preobese, even…
Apr 16, 2024
Treatment challenges in patients with nAMD
by: Lynda Charters David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab. Reviewed by David Eichenbaum, MD David Eichenbaum, MD, from Retina Vitreous Associates of Florida and the Morsani College…
Apr 16, 2024
Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410
by: Sydney M Crago The Phase 1/2 study includes a dose-escalation phase of the study featuring 3 cohorts each one receiving either a low, medium, or high dose of OCU410.…
Apr 15, 2024
New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain
By Lisa Marie Basile | Fact-checked by Davi Sherman -Published March 29, 2024 Key Takeaways New research has drawn a link between vitamin D deficiency (VDD) and diabetic peripheral neuropathy (DPN) in elderly adults with type…
Apr 10, 2024
The Complete Eye Health & Nutrition Guide: Eye Foods
New lower price- The Complete Eye Health & Nutrition Guide: Eye Foods New price $15.00 + $9.95 mailing costs- Limited time Please click here to order your today: https://macularhope.org/shop/y7